Table 1.

The brief demographic, clinical, imaging, and procedural details along with the end point and outcomes of the bedside PTBD

S. No	Age	Sex	Imaging available*	Level of obstruction	Probable cause of obstruction	Primary confluence	IHBRD (> 3 mm)	Diameter of peripheral duct (mm)	Bismuth-Corlette classification	Coagulation profile (platelet counts, PTI)	Side of procedure	Catheter size	Endpoint	In-hospital outcome
1	43	M	MRCP	Distal	Benign stricture	Patent	Yes	3	–	190 K, 80%	Left	8 F	Internalized	Discharged
2	85	M	CT	Hilar	Cholangiocarcinoma	Not patent	Yes	6	Type IV	120 K, 81%	Bilateral	8 F	External drainage	Mortality
3	27	F	CT	Distal	Calculi	Patent	No	2	–	150 K, 85%	Left	6 F	External drainage	Mortality
4	67	M	CT	Distal	Periampullary carcinoma	Patent	No	2.3	–	230 K, 90%	Right	7 F	External drainage	Mortality
5	55	M	CT	Distal	Periampullary carcinoma	Patent	Yes	3.8	–	320 K, 79%	Left	8 F	External drainage	Mortality
6	70	F	USG	Hilar	Carcinoma gallbladder	Not patent	Yes	3.5	Type II	450 K, 62%	Left	8 F	Internalized	Discharged
7	37	M	CT	Hilar	Cholangiocarcinoma	Not patent	Yes	4.2	Type II	61 K, 55%	Right	8 F	External drainage	Mortality
8	46	M	CT	Hilar	Cholangiocarcinoma	Not patent	Yes	4.5	Type II	480 K, 14%	Left	8 F	External drainage	Mortality
9	63	M	CT	Distal	Carcinoma head of pancreas	Patent	Yes	4.1	–	280 K, 86%	Right	8 F	External drainage	Discharged
10	45	F	CT	Distal	Carcinoma head of pancreas	Patent	No	2	–	320 K, 92%	Right	6 F	External drainage	Discharged

M male, F female, MRCP magnetic resonance cholangiopancreatography, CT computed tomography, USG ultrasonography, IHBRD intrahepatic biliary radicles dilatation, PTI prothrombin time index, F French

*Depicts latest pre-procedural imaging